Predictive Technology Group, Inc. (PREDQ)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 28, 2025
-99.80%
Market Cap 317.00
Revenue (ttm) 19.17M
Net Income (ttm) -68.15M
Shares Out 316.67M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,650
Average Volume 409
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0403
Beta -0.43
RSI 43.44
Earnings Date n/a

About PREDQ

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditio... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2005
Employees 63
Stock Exchange OTCMKTS
Ticker Symbol PREDQ
Full Company Profile

Financial Performance

In 2020, PREDQ's revenue was $24.44 million, a decrease of -43.80% compared to the previous year's $43.49 million. Losses were -$85.77 million, 460.4% more than in 2019.

Financial Statements

News

There is no news available yet.